CTx is preclinical biotech developing the second generation of therapeutic & intelligent mRNA.

Biotechnology

Combined Therapeutics

Combined Therapeutics' headquarters in Cambridge, MA, United States

Romain Micol

Maxime Lesieur

Ronald Kaunfer

Sarah Cooleybeck

Devenand Crease

Pierre Matussiere

Robert Langer

Dan Anderson

Ronald E. Kaunfer

David Neafus

The Advisory Team at Combined Therapeutics provides strategic guidance and expertise to enhance the development of next-generation therapeutic mRNA technologies. Leveraging their diverse backgrounds in biotechnology, medicine, and regulatory affairs, the team advises on research direction, clinical trial design, and market strategy, ensuring that CTx remains at the forefront of innovation in the biotech field.

Advisory Team

The Leadership Team at Combined Therapeutics is responsible for guiding the strategic direction of the company and overseeing the development of innovative mRNA-based therapies. This team collaborates on key decisions related to research and development, ensuring that the scientific and operational aspects align with the company's vision of advancing cutting-edge biotechnology. Their expertise in formulation and process development drives the preclinical progress of the next generation of therapeutic mRNA solutions.

Leadership Team

The Research and Development team at Combined Therapeutics focuses on advancing innovative therapeutic solutions by optimizing mRNA formulations and processes. This team conducts preclinical studies to evaluate the efficacy and safety of next-generation mRNA technologies, bridging the gap between scientific discovery and practical application to enhance patient outcomes.

Combined Therapeutics

Org chart

Board & advisors

Teams

Advisory Team

Leadership Team

Research and Development

Offices

Combined Therapeutics

Org chart

Board & advisors

Teams

Advisory Team

Leadership Team

Research and Development

Offices

Related companies